Expression of leukemia inhibitory factor in craniopharyngioma
It has recently been reported that overexpression of leukemia inhibitory factor (LIF) in mice transgenic for LIF causes invagination of the anterior wall of Rathke's pouch leading to the formation of cysts lined by LIF immunoreactive epithelial cells. Strong immunoreactivity was also found in h...
Gespeichert in:
Veröffentlicht in: | Endocrine pathology 1999-06, Vol.10 (2), p.103-108 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 108 |
---|---|
container_issue | 2 |
container_start_page | 103 |
container_title | Endocrine pathology |
container_volume | 10 |
creator | Tran, A Kovacs, K Stefaneanu, L Kontogeorgos, G Scheithauer, B W Melmed, S |
description | It has recently been reported that overexpression of leukemia inhibitory factor (LIF) in mice transgenic for LIF causes invagination of the anterior wall of Rathke's pouch leading to the formation of cysts lined by LIF immunoreactive epithelial cells. Strong immunoreactivity was also found in human Rathke's cleft cysts. Because such cysts and craniopharyngiomas share a common histogenesis, we raised the question of whether LIF is also expressed in craniopharyngioma.Fourteen histologically verified craniopharyngiomas of adamantinomatous type were examined for LIF immunoreactivity using the streptavidin-biotin-peroxidase complex method. Rabbit-anti-LIF antibody dilution 1:40) was applied to tissues having undergone antigen retrieval (microwaving in citrate buffer at pH 6). For positive control, nontumorous pituitary tissues were used. Primary antibody substituted with phosphate-buffered saline served as a negative control.By immunocytochemistry, the epithelial cells of all 14 craniopharyngiomas were LIF immunoreactive, showing varying degrees of staining intensity. In comparison, the connective tissue components of the tumors were immunonegative.Our study provides evidence that LIF is expressed in the epithelial cells of craniopharyngioma. Further investigation is required to elucidate the possible role of LIF in the development and progression of craniopharyngiomas. |
doi_str_mv | 10.1007/BF02739822 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1812442291</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2410504801</sourcerecordid><originalsourceid>FETCH-LOGICAL-c378t-e4c8643edb4931fb7fdc502871d33e0ef3bed9e1c44120564afd07ea6ab90f0d3</originalsourceid><addsrcrecordid>eNpdkE1Lw0AQhhdRbK1e_AESPIkQnf1INnvwoKVVoeBFz2GzmbVbk2zdbcD-eyP1Azy9w_DwMvMQckrhigLI67s5MMlVwdgeGdMsUymAkvvDDCJPuZL5iBzFuAKgHIAdkhGTGVWMijG5mX2sA8bofJd4mzTYv2HrdOK6pavcxodtYrUZctgkJujO-fVSh2336nyrj8mB1U3Ek--ckJf57Hn6kC6e7h-nt4vUcFlsUhSmyAXHuhKKU1tJW5sMWCFpzTkCWl5hrZAaISiDLBfa1iBR57pSYKHmE3Kx610H_95j3JStiwabRnfo-1jSgjIhGFN0QM__oSvfh264riykkpBJCgN0uYNM8DEGtOU6uHZ4q6RQfjkt_5wO8Nl3Y1-1WP-iPxL5J7uTcJQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>879705710</pqid></control><display><type>article</type><title>Expression of leukemia inhibitory factor in craniopharyngioma</title><source>Springer Nature - Complete Springer Journals</source><creator>Tran, A ; Kovacs, K ; Stefaneanu, L ; Kontogeorgos, G ; Scheithauer, B W ; Melmed, S</creator><creatorcontrib>Tran, A ; Kovacs, K ; Stefaneanu, L ; Kontogeorgos, G ; Scheithauer, B W ; Melmed, S</creatorcontrib><description>It has recently been reported that overexpression of leukemia inhibitory factor (LIF) in mice transgenic for LIF causes invagination of the anterior wall of Rathke's pouch leading to the formation of cysts lined by LIF immunoreactive epithelial cells. Strong immunoreactivity was also found in human Rathke's cleft cysts. Because such cysts and craniopharyngiomas share a common histogenesis, we raised the question of whether LIF is also expressed in craniopharyngioma.Fourteen histologically verified craniopharyngiomas of adamantinomatous type were examined for LIF immunoreactivity using the streptavidin-biotin-peroxidase complex method. Rabbit-anti-LIF antibody dilution 1:40) was applied to tissues having undergone antigen retrieval (microwaving in citrate buffer at pH 6). For positive control, nontumorous pituitary tissues were used. Primary antibody substituted with phosphate-buffered saline served as a negative control.By immunocytochemistry, the epithelial cells of all 14 craniopharyngiomas were LIF immunoreactive, showing varying degrees of staining intensity. In comparison, the connective tissue components of the tumors were immunonegative.Our study provides evidence that LIF is expressed in the epithelial cells of craniopharyngioma. Further investigation is required to elucidate the possible role of LIF in the development and progression of craniopharyngiomas.</description><identifier>ISSN: 1046-3976</identifier><identifier>EISSN: 1559-0097</identifier><identifier>DOI: 10.1007/BF02739822</identifier><identifier>PMID: 27519214</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Cysts ; Leukemia</subject><ispartof>Endocrine pathology, 1999-06, Vol.10 (2), p.103-108</ispartof><rights>Humana Press Inc. 1999</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c378t-e4c8643edb4931fb7fdc502871d33e0ef3bed9e1c44120564afd07ea6ab90f0d3</citedby><cites>FETCH-LOGICAL-c378t-e4c8643edb4931fb7fdc502871d33e0ef3bed9e1c44120564afd07ea6ab90f0d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27519214$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tran, A</creatorcontrib><creatorcontrib>Kovacs, K</creatorcontrib><creatorcontrib>Stefaneanu, L</creatorcontrib><creatorcontrib>Kontogeorgos, G</creatorcontrib><creatorcontrib>Scheithauer, B W</creatorcontrib><creatorcontrib>Melmed, S</creatorcontrib><title>Expression of leukemia inhibitory factor in craniopharyngioma</title><title>Endocrine pathology</title><addtitle>Endocr Pathol</addtitle><description>It has recently been reported that overexpression of leukemia inhibitory factor (LIF) in mice transgenic for LIF causes invagination of the anterior wall of Rathke's pouch leading to the formation of cysts lined by LIF immunoreactive epithelial cells. Strong immunoreactivity was also found in human Rathke's cleft cysts. Because such cysts and craniopharyngiomas share a common histogenesis, we raised the question of whether LIF is also expressed in craniopharyngioma.Fourteen histologically verified craniopharyngiomas of adamantinomatous type were examined for LIF immunoreactivity using the streptavidin-biotin-peroxidase complex method. Rabbit-anti-LIF antibody dilution 1:40) was applied to tissues having undergone antigen retrieval (microwaving in citrate buffer at pH 6). For positive control, nontumorous pituitary tissues were used. Primary antibody substituted with phosphate-buffered saline served as a negative control.By immunocytochemistry, the epithelial cells of all 14 craniopharyngiomas were LIF immunoreactive, showing varying degrees of staining intensity. In comparison, the connective tissue components of the tumors were immunonegative.Our study provides evidence that LIF is expressed in the epithelial cells of craniopharyngioma. Further investigation is required to elucidate the possible role of LIF in the development and progression of craniopharyngiomas.</description><subject>Cysts</subject><subject>Leukemia</subject><issn>1046-3976</issn><issn>1559-0097</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdkE1Lw0AQhhdRbK1e_AESPIkQnf1INnvwoKVVoeBFz2GzmbVbk2zdbcD-eyP1Azy9w_DwMvMQckrhigLI67s5MMlVwdgeGdMsUymAkvvDDCJPuZL5iBzFuAKgHIAdkhGTGVWMijG5mX2sA8bofJd4mzTYv2HrdOK6pavcxodtYrUZctgkJujO-fVSh2336nyrj8mB1U3Ek--ckJf57Hn6kC6e7h-nt4vUcFlsUhSmyAXHuhKKU1tJW5sMWCFpzTkCWl5hrZAaISiDLBfa1iBR57pSYKHmE3Kx610H_95j3JStiwabRnfo-1jSgjIhGFN0QM__oSvfh264riykkpBJCgN0uYNM8DEGtOU6uHZ4q6RQfjkt_5wO8Nl3Y1-1WP-iPxL5J7uTcJQ</recordid><startdate>19990601</startdate><enddate>19990601</enddate><creator>Tran, A</creator><creator>Kovacs, K</creator><creator>Stefaneanu, L</creator><creator>Kontogeorgos, G</creator><creator>Scheithauer, B W</creator><creator>Melmed, S</creator><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>19990601</creationdate><title>Expression of leukemia inhibitory factor in craniopharyngioma</title><author>Tran, A ; Kovacs, K ; Stefaneanu, L ; Kontogeorgos, G ; Scheithauer, B W ; Melmed, S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c378t-e4c8643edb4931fb7fdc502871d33e0ef3bed9e1c44120564afd07ea6ab90f0d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Cysts</topic><topic>Leukemia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tran, A</creatorcontrib><creatorcontrib>Kovacs, K</creatorcontrib><creatorcontrib>Stefaneanu, L</creatorcontrib><creatorcontrib>Kontogeorgos, G</creatorcontrib><creatorcontrib>Scheithauer, B W</creatorcontrib><creatorcontrib>Melmed, S</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Endocrine pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tran, A</au><au>Kovacs, K</au><au>Stefaneanu, L</au><au>Kontogeorgos, G</au><au>Scheithauer, B W</au><au>Melmed, S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression of leukemia inhibitory factor in craniopharyngioma</atitle><jtitle>Endocrine pathology</jtitle><addtitle>Endocr Pathol</addtitle><date>1999-06-01</date><risdate>1999</risdate><volume>10</volume><issue>2</issue><spage>103</spage><epage>108</epage><pages>103-108</pages><issn>1046-3976</issn><eissn>1559-0097</eissn><abstract>It has recently been reported that overexpression of leukemia inhibitory factor (LIF) in mice transgenic for LIF causes invagination of the anterior wall of Rathke's pouch leading to the formation of cysts lined by LIF immunoreactive epithelial cells. Strong immunoreactivity was also found in human Rathke's cleft cysts. Because such cysts and craniopharyngiomas share a common histogenesis, we raised the question of whether LIF is also expressed in craniopharyngioma.Fourteen histologically verified craniopharyngiomas of adamantinomatous type were examined for LIF immunoreactivity using the streptavidin-biotin-peroxidase complex method. Rabbit-anti-LIF antibody dilution 1:40) was applied to tissues having undergone antigen retrieval (microwaving in citrate buffer at pH 6). For positive control, nontumorous pituitary tissues were used. Primary antibody substituted with phosphate-buffered saline served as a negative control.By immunocytochemistry, the epithelial cells of all 14 craniopharyngiomas were LIF immunoreactive, showing varying degrees of staining intensity. In comparison, the connective tissue components of the tumors were immunonegative.Our study provides evidence that LIF is expressed in the epithelial cells of craniopharyngioma. Further investigation is required to elucidate the possible role of LIF in the development and progression of craniopharyngiomas.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>27519214</pmid><doi>10.1007/BF02739822</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1046-3976 |
ispartof | Endocrine pathology, 1999-06, Vol.10 (2), p.103-108 |
issn | 1046-3976 1559-0097 |
language | eng |
recordid | cdi_proquest_miscellaneous_1812442291 |
source | Springer Nature - Complete Springer Journals |
subjects | Cysts Leukemia |
title | Expression of leukemia inhibitory factor in craniopharyngioma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T16%3A12%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20of%20leukemia%20inhibitory%20factor%20in%20craniopharyngioma&rft.jtitle=Endocrine%20pathology&rft.au=Tran,%20A&rft.date=1999-06-01&rft.volume=10&rft.issue=2&rft.spage=103&rft.epage=108&rft.pages=103-108&rft.issn=1046-3976&rft.eissn=1559-0097&rft_id=info:doi/10.1007/BF02739822&rft_dat=%3Cproquest_cross%3E2410504801%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=879705710&rft_id=info:pmid/27519214&rfr_iscdi=true |